Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

AIRGAIN INC (AIRG)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 3
  • 1 comments

Airgain Expands Public Safety and Utility Connectivity Portfolio with FirstNet, Built with AT&T

Market reaction Comment Full text

CADENCE DESIGN SYSTEMS INC (CDNS)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Cadence’s Richard Gu to Present at Nasdaq Conference

Market reaction Comment Full text

STRATTEC SECURITY CORP (STRT)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Strattec to Present at the East Coast IDEAS Investor Conference

Market reaction Comment Full text

PARK HOTELS & RESORTS INC. (PK)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Park Hotels & Resorts Inc. Announces Second Quarter 2026 Earnings Conference Call on August 7, 2026

Market reaction Comment Full text

ARDENT HEALTH, INC. (ARDT)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 3
  • 1 comments

Ardent Health Appoints Dave Caspers as CEO

Market reaction Comment Full text

MICROCHIP TECHNOLOGY INC (MCHP)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Microchip Technology to Present at the 2026 Evercore Global TMT Conference

Market reaction Comment Full text

CADRE HOLDINGS, INC. (CDRE)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Cadre Holdings Subsidiary Safariland Selected as Ballistic Provider for FBI Armor Contract

Market reaction Comment Full text

UGI CORP /PA/ (UGI)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

UGI Corporation Achieves All 2025 ESG Commitments, Releases Annual Sustainability Report

Market reaction Comment Full text

ABUNDIA GLOBAL IMPACT GROUP, INC. (AGIG)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 2
  • 1 comments

Abundia Global Impact Group to Participate in the 16th Annual ROTH London Conference

Market reaction Comment Full text

AGILENT TECHNOLOGIES, INC. (A)

  • Business News
  • June 02, 2026, 20:15 UTC
  • 3
  • 1 comments

Agilent Receives FDA Approval for Expanded Use of PD-L1 IHC 22C3 pharmDx on Dako Omnis in Esophageal Squamous Cell Carcinoma, Triple-Negative Breast Cancer, Cervical Cancer, and Gastric or Gastroesophageal Junction Adenocarcinoma

Market reaction Comment Full text
  • Previous
  • 1173
  • 1174
  • 1175
  • 1176
  • 1177
  • Next

Search

News categories

  • Technical Exchange News(13393)
  • Event(6229)
  • SEC News(343318)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(189827)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin